Retrospective data from 30 HCC patients who received anti-PD-1 therapy demonstrated that circUHRF1 expression level is much higher in the patients with progressive disease versus individuals with partial response or stable disease. The gene discussed is PDCD1; the disease is hepatocellular carcinoma.